Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 216337015 | Liposomal doxorubicin hydrochloride 50mg/25mL infusion conc | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1475475018 | Liposomal doxorubicin hydrochloride 2mg/mL infusion concentrate 25mL vial (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1490079011 | Liposomal doxorubicin hydrochloride 2mg/mL infusion concentrate 25mL vial | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2162198013 | Liposomal doxorubicin hydrochloride 50mg/25mL infusion concentrate (pdr for recon)+dil | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2693247018 | Doxorubicin (liposomal) 50mg/25ml solution for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Liposomal doxorubicin hydrochloride 2mg/mL infusion concentrate 25mL vial | Is a | Product containing doxorubicin (medicinal product) | false | Inferred relationship | Some | ||
| Liposomal doxorubicin hydrochloride 2mg/mL infusion concentrate 25mL vial | Has active ingredient | Doxorubicin (substance) | false | Inferred relationship | Some | ||
| Liposomal doxorubicin hydrochloride 2mg/mL infusion concentrate 25mL vial | Is a | Product containing doxorubicin liposome | false | Inferred relationship | Some | ||
| Liposomal doxorubicin hydrochloride 2mg/mL infusion concentrate 25mL vial | Has manufactured dose form | Injection | false | Inferred relationship | Some | ||
| Liposomal doxorubicin hydrochloride 2mg/mL infusion concentrate 25mL vial | Has active ingredient | Daunorubicin hydrochloride liposome (substance) | false | Inferred relationship | Some | ||
| Liposomal doxorubicin hydrochloride 2mg/mL infusion concentrate 25mL vial | Has active ingredient | Doxorubicin liposome (substance) | false | Inferred relationship | Some | ||
| Liposomal doxorubicin hydrochloride 2mg/mL infusion concentrate 25mL vial | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
| Liposomal doxorubicin hydrochloride 2mg/mL infusion concentrate 25mL vial | Has manufactured dose form | Infusion concentrate | false | Inferred relationship | Some | ||
| Liposomal doxorubicin hydrochloride 2mg/mL infusion concentrate 25mL vial | Is a | Doxorubicin-containing product in parenteral dose form | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR